TransMedics Group Files 8-K on Shareholder Vote
Ticker: TMDX · Form: 8-K · Filed: May 28, 2024 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
TransMedics Group held a shareholder vote on May 23rd, filing the details today.
AI Summary
TransMedics Group, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders on May 23, 2024. The filing details the company's principal executive offices located at 200 Minuteman Road, Andover, Massachusetts.
Why It Matters
This filing informs investors about significant corporate actions, specifically a vote by security holders, which can impact company governance and future strategic decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a shareholder vote and does not appear to contain new material financial or operational risks.
Key Players & Entities
- TransMedics Group, Inc. (company) — Registrant
- May 23, 2024 (date) — Date of earliest event reported
- May 28, 2024 (date) — Date of report
- 200 Minuteman Road, Andover, Massachusetts (location) — Principal Executive Offices
FAQ
What was the specific nature of the matters submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders on May 23, 2024, but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 23, 2024.
What is the principal executive office address for TransMedics Group, Inc.?
The principal executive offices of TransMedics Group, Inc. are located at 200 Minuteman Road, Andover, Massachusetts, 01810.
What is the SEC file number for TransMedics Group, Inc.?
The SEC file number for TransMedics Group, Inc. is 001-38891.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 613 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-05-28 16:15:32
Filing Documents
- d801801d8k.htm (8-K) — 39KB
- 0001193125-24-148102.txt ( ) — 155KB
- tmdx-20240523.xsd (EX-101.SCH) — 3KB
- tmdx-20240523_lab.xml (EX-101.LAB) — 17KB
- tmdx-20240523_pre.xml (EX-101.PRE) — 11KB
- d801801d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSMEDICS GROUP, INC. Date: May 28, 2024 By: /s/ Stephen Gordon Name: Stephen Gordon Title: Chief Financial Officer and Treasurer